LogiCare3PL announced it has been selected by Harrow (HROW) as a distribution partner for Harrow’s portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is providing both non-title and 3PL title distribution services, supporting distribution of Harrow’s products across the U.S. market. The agreement, effective February 1, 2026, covers LogiCare3PL’s full suite of 3PL services, including non-title logistics support and title distribution for Harrow’s products. Both organizations anticipate continued collaboration as Harrow expands its product offerings.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- Harrow management to meet virtually with BTIG
- Harrow price target lowered to $65 from $74 at B. Riley
- Harrow Health Expands Senior Notes Offering for Growth
- Harrow Health Prices $50 Million Senior Notes Offering
- Opportunistic Capital Strategy and Iheezo Growth Opportunities Support Harrow Health Buy Rating